Clinical trials
Hematologic Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Assiut University | 3 |
| Hellenic Society of Hematology | 3 |
| Charite University, Berlin, Germany | 2 |
| Fairview University Medical Center | 2 |
| University Hospital, Strasbourg, France | 2 |
| Acrotech Biopharma Inc. | 1 |
| Anhui Provincial Hospital | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 68 |
| Neoplasms | 11 |
| Multiple Myeloma | 6 |
| Neoplasms, Plasma Cell | 6 |
| Rare Diseases | 6 |
| Anemia | 5 |
| Anemia, Aplastic | 5 |
| Blood Protein Disorders | 5 |
| Hematologic Neoplasms | 5 |
| Immune System Diseases | 4 |
Trials
Showing 26 to 50 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.